血液腫瘍研究室　2011年度業績−学会

  1. 難波宏美、藤原孝記、金子　強、永友ひとみ、蟹井はるか、笠井英利、大曾根和子、前島恵理子、富山秀和、脇本信博、白藤尚毅
    増悪時にE抗原の消失を認めた骨髄異形成症候群の１例．第59回日本輸血細胞治療学会, 2011
  2. 金子　強、藤原孝記、前島恵理子、大曾根和子、難波宏美、蟹井はるか、笠井英利、永友ひとみ、富山秀和、脇本信博、白藤尚毅
    当院における洗浄血液製剤の使用状況．第59回日本輸血細胞治療学会, 2011
  3. Ryosuke Shirasaki, Haruko Tashiro, Tadashi Yamamoto, Yoko Oka, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji.
    Myofibroblasts originating from myelogenous leukemia cases form blastoma in severe combined immunodeficiency mice．The 9th Stem Cell Research Symposium, 2011
  4. Haruko Tashiro, Ryosuke Shirasaki, Tadashi Yamamoto, Yoko Oka, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji
    Expression cloning of a reprogramming activity that induces bone marrow adherent myofibroblasts toward hematopoietic stem cells: Interleukin 1β promotes the expression of CD34 and cytokine receptors．The 9th Stem Cell Research Symposium, 2011
  5. 白崎　良輔、田代　晴子、山本　義、岡　陽子、秋山　暢、川杉　和夫、白藤　尚毅
    ATG療法後にEBV関連リンパ増殖性疾患を発症した再生不良性貧血の１例．第166回日本血液学会例会, 2011
  6. Yoko Oka, Haruko Tashiro, Ryosuke Shirasaki, Tadashi Yamamoto, Nobu Akiyama, Kazuo Kawasugi, Shin Fujimori, Naoki Shirafuji.
    Hyperuricemia associated with hematological malignancies is caused by an insufficient urinary excretion．第72回日本血液学会総会、第52回日本臨床血液学会総会, 2011
  7. Ryosuke Shirasaki, Nobu Akiyama, Haruko Tashiro, Tadashi Yamamoto, Yoko Oka, Kazuo Kawasugi, Naoki Shirafuji.
    Retrospective analysis of risk factors for febrile neutropenia．第72回日本血液学会総会、第52回日本臨床血液学会総会, 2011
  8. Haruko Tashiro, Ryosuke Shirasaki, Tadashi Yamamoto, Yoko Oka, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji
    Relapse after allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies: single institutional analysi．第72回日本血液学会総会、第52回日本臨床血液学会総会, 2011
  9. 野村高広、岡　陽子、山本　義、白崎　良輔、田代　晴子、秋山　暢、川杉　和夫、白藤　尚毅
    自己免疫性疾患合併MALTリンパ腫にRituximab単剤療法が著効した１例．第167回日本血液学会例会, 2012
  10. 田代　晴子、山本　義、岡　陽子、白崎　良輔、秋山　暢、川杉　和夫、白藤　尚毅
    免疫抑制剤の中止により再寛解が得られた同種骨髄移植後早期再発急性リンパ性白血病．第34回日本造血細胞移植学会, 2012
  11. Ryosuke Shirasaki, Haruko Tashiro, Tadashi Yamamoto, Yoko Oka, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji.
    Myofibroblasts originating from myelogenous leukemia cases form blastoma in severe combined immunodeficiency mice．16th EHA, 2011
  12. Haruko Tashiro, Ryosuke Shirasaki, Tadashi Yamamoto, Yoko Oka, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji
    Expression cloning of a reprogramming activity that induces bone marrow adherent myofibroblasts toward hematopoietic stem cells: Interleukin 1β promotes the expression of CD34 and cytokine receptors．16th EHA, 2011
  13. Yoko Oka, Ryosuke Shirasaki, Haruko Tashiro, Tadashi Yamamoto, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji
    Tcf3/Pbx1 fusion molecule induces the transcription of Prox-1 and vascular endothelial growth factor receptor type-3．53rd ASH, 2011
  14. Haruko Tashiro, Ryosuke Shirasaki, Yoko Oka, Tadashi Yamamoto, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji
    Interleukin-1β promotes the expression of CD34 and granulocyte colony-stimulating factor-receptor in adult dermal fibroblast．53rd ASH, 2011
  15. Takeshita A, Ono R, Kojima Y, Akiyama N, et al：
    Efficacy of gamtuzumab ozogamicin (GO) monotherapy on relapsed refractory acute promyelocytic lenkemia (APL) 53rd ASH, 2011
  16. Ryosuke Shirasaki, Haruko Tashiro, Yoko Oka, Tadashi Yamamoto, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji
    CD56(+)CD146(+) myofibroblasts originating from normal human bone marrow cells proliferated to form tumors in severe combined immunodeficiency mice．53rd ASH, 2011
  17. 秋山　暢
    ガイドラインだけでは解決できないFN難治例へのアプローチ．第73回日本血液学会総会, 2011
  18. 秋山　暢
    発熱性好中球減少症に対する治療戦略．発熱性好中球減少症の二次・三次治療　グラム陽性感染を巡って．第59回日本化学療法学会総会, 2011
  19. 秋山　暢、藤田浩之、木藤克之、他
    JALSG AML201 試験における急性骨髄性白血病の感染症に関する解析と感染症起因菌の年次推移．第85回日本感染症学会総会, 2011

コメントは停止中です。